Organizer
Agilent Technologies
Agilent Technologies
Analytical scientists and clinical researchers worldwide rely on Agilent to help fulfill their most complex laboratory demands. Our instruments, software, services and consumables address the full range of scientific and laboratory management needs.
Tags
HPLC
LinkedIn Logo

Resolving GLP-1 Impurities Using Orthogonal RPLC and HILIC Approaches

RECORD | Already taken place Fr, 12.6.2026
Episode 5 of Peptide 360 explores orthogonal RPLC and HILIC strategies to improve GLP-1 impurity separation, strengthen profiling confidence, and support QC and regulatory readiness.
Go to the webinar
Agilent Technologies: Peptide 360: Mastering the Invisible from Sequence to Confidence
Agilent Technologies: Peptide 360: Mastering the Invisible from Sequence to Confidence

A five-part webinar series unlocking advanced insights across the Peptide therapeutics workflows

Peptide therapeutics are reshaping modern medicine, with GLP-1 receptor agonists driving rapid advances in metabolic disease treatment. As peptide and GLP-1 programs scale, scientists face increasing pressure to generate data that is accurate, defensible, and decision-ready across development stages.

Peptide 360 is designed to guide scientists through this complexity, following the peptide workflow from sequence insight to confident development decisions.

Who Should Attend?

This series is designed for scientists and technical leaders working in peptide and GLP-1 discovery and development, analytical development, characterization, Bioanalysis, DMPK, translational research, CMC, QA/QC, and regulatory-facing analytical roles

How the Series Works?
  • Register once for the full series
  • Pre-submit questions for live expert responses
  • Access recordings anytime after each session
  • Certificate of attendance provided

Episode 5: Resolving GLP-1 Impurities Using Orthogonal RPLC and HILIC Approaches

GLP-1 receptor agonists exhibit structural complexity and susceptibility to degradation, making robust impurity separation essential for quality control and regulatory compliance. This session highlights the use of orthogonal chromatographic approaches, reversed-phase liquid chromatography (RPLC) and hydrophilic interaction chromatography (HILIC), to improve impurity resolution and detection.

Attendees will learn practical method development strategies, including gradient design, column selection, temperature control, and mobile phase optimization. The session demonstrates how combining orthogonal separations enhances confidence in impurity profiling and supports reliable characterization of GLP-1 analogs in development and QC environments.

Presenter: Andrea Ngai (Biopharma Technical Specialist, Agilent Technologies, Inc.)

Presenter: Ashish Pargaonkar, Ph.D. (Biopharma Applications Specialist, Agilent Technologies, Inc.)

Agilent Technologies
LinkedIn Logo
 

Related content

Impurity Monitoring of GLP-1 Therapeutic Peptide RetatrutideUsing a 2D-LC/TOF System

Posters
| 2026 | Agilent Technologies (ASMS)
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, 2D-LC
Manufacturer
Agilent Technologies
Industries
Pharma & Biopharma

Increased sensitivity for low-input label-free proteomics using the Orbitrap Astral MS and μPAC Neo Plus Columns

Applications
| 2026 | Thermo Fisher Scientific
Instrumentation
LC/HRMS, LC/Orbitrap, LC/MS, LC/MS/MS
Manufacturer
Thermo Fisher Scientific
Industries
Proteomics

Mind the pressure in preparative up-scaling – effects of particle size and solvent composition on back pressure

Technical notes
| 2026 | KNAUER
Instrumentation
HPLC, Consumables, LC columns
Manufacturer
KNAUER
Industries
Other

Two-Step Matrix Deposition for Improved MS Imaging Resolution

Posters
| 2026 | Shimadzu (ASMS)
Instrumentation
LC/MS, LC/MS/MS, LC/TOF, LC/HRMS, MALDI, MS Imaging
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

Smart Monitoring & Optimization Solutions for SMB Processes: In-Line and Off-Line Tools for SMB Systems

Technical notes
| 2026 | KNAUER
Instrumentation
HPLC
Manufacturer
KNAUER
Industries
Pharma & Biopharma
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike